<p>The early diagnosis of neurological disorders and the advancement of non-invasive clinical sensing both demand accurate brain tissue characterization, a task conventional optical techniques struggle to deliver due to limitations in sensitivity, stability, and interpretability. To address these gaps, we propose an approach that integrates PCF-based biosensing with machine learning, all within an explainable AI paradigm, to achieve highly accurate brain tissue analysis. The designed PCF incorporates a gold-coated plasmonic structure, numerically optimized using the Finite Element Method (FEM), to generate high-fidelity optical datasets. Six regression models including, Multiple Linear Regression (MLR), Decision Tree Regressor (DTR), Support Vector Regressor (SVR), Random Forest Regressor (RFR), Gradient Boosting Regressor (GBR), and XGBoost Regressor (XGBR) were evaluated to predict key optical parameters, including confinement loss (CLoss) and wavelength sensitivity (WS). Explainable AI methods, namely SHAP and LIME, were implemented to interpret global and local feature contributions, ensuring transparency and trustworthiness. Experimental outcomes demonstrate that the XGBR model achieved superior performance with <InlineEquation ID="IEq1"> <EquationSource Format="TEX">\(R^{2}=0.9663\)</EquationSource> </InlineEquation>, <InlineEquation ID="IEq2"> <EquationSource Format="TEX">\(MAE=8.47\times 10^{-6}\)</EquationSource> </InlineEquation>, and <InlineEquation ID="IEq3"> <EquationSource Format="TEX">\(MSE=3.75\times 10^{-5}\)</EquationSource> </InlineEquation>, while attaining exceptional wavelength sensitivity of <InlineEquation ID="IEq4"> <EquationSource Format="TEX">\(13357.66\,\text {nm/RIU}\)</EquationSource> </InlineEquation> and a figure of merit (FOM) of <InlineEquation ID="IEq5"> <EquationSource Format="TEX">\(49.67\,\text {RIU}^{-1}\)</EquationSource> </InlineEquation>. The findings validate NeuroPCF-ML as a highly sensitive, interpretable, and data-driven tool for next-generation photonic biosensors in clinical neurodiagnostics.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

NeuroPCF-ML: An Explainable Machine Learning Approach for Brain Tissue Characterization through Photonic Crystal Fiber Sensing

  • Sonia Akter,
  • Hasan Abdullah,
  • Mohammad Asaduzzaman Khan

摘要

The early diagnosis of neurological disorders and the advancement of non-invasive clinical sensing both demand accurate brain tissue characterization, a task conventional optical techniques struggle to deliver due to limitations in sensitivity, stability, and interpretability. To address these gaps, we propose an approach that integrates PCF-based biosensing with machine learning, all within an explainable AI paradigm, to achieve highly accurate brain tissue analysis. The designed PCF incorporates a gold-coated plasmonic structure, numerically optimized using the Finite Element Method (FEM), to generate high-fidelity optical datasets. Six regression models including, Multiple Linear Regression (MLR), Decision Tree Regressor (DTR), Support Vector Regressor (SVR), Random Forest Regressor (RFR), Gradient Boosting Regressor (GBR), and XGBoost Regressor (XGBR) were evaluated to predict key optical parameters, including confinement loss (CLoss) and wavelength sensitivity (WS). Explainable AI methods, namely SHAP and LIME, were implemented to interpret global and local feature contributions, ensuring transparency and trustworthiness. Experimental outcomes demonstrate that the XGBR model achieved superior performance with \(R^{2}=0.9663\) , \(MAE=8.47\times 10^{-6}\) , and \(MSE=3.75\times 10^{-5}\) , while attaining exceptional wavelength sensitivity of \(13357.66\,\text {nm/RIU}\) and a figure of merit (FOM) of \(49.67\,\text {RIU}^{-1}\) . The findings validate NeuroPCF-ML as a highly sensitive, interpretable, and data-driven tool for next-generation photonic biosensors in clinical neurodiagnostics.